Betty Chewning

Dr. Betty Chewning

School of Pharmacy, University of Wisconsin-Madison, Madison, WI 53705, USA

Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2012 in Patient Education and Counseling
Verified
Journal Article
Closed access
BCBetty Chewning
Betty Chewning
CBCarma L. Bylund
Carma L. Bylund
BSBupendra Shah
Bupendra Shah
NANeeraj K. Arora
Neeraj K. Arora
JGJennifer A. Gueguen
Jennifer A. Gueguen
GMGregory Makoul
Gregory Makoul

1 March 2015 in Patient Education and Counseling
Verified
Journal Article
Closed access
OAOnur Asan
Onur Asan
HYHenry N. Young
Henry N. Young
BCBetty Chewning
Betty Chewning
EMEnid Montague
Enid Montague

11 April 2012 in International Journal of Pharmacy Practice
Verified
Journal Article
Closed access
PDF file
DTDerjung M. Tarn
Derjung M. Tarn
DPDebora A Paterniti
Debora A Paterniti
NWNeil S. Wenger
Neil S. Wenger
BWBradley R. Williams
Bradley R. Williams
BCBetty Chewning
Betty Chewning

1 May 2014 in Research in Social and Administrative Pharmacy
Verified
Journal Article
Closed access
PPPallavi D. Patwardhan
Pallavi D. Patwardhan
MAMohamed E. Amin
Mohamed E. Amin
BCBetty Chewning
Betty Chewning

13 June 2019 in Pharmacy
Verified
Journal Article
Open access
PDF file
TTTanvee Thakur
Tanvee Thakur
MFMeredith Frey
Meredith Frey
BCBetty Chewning
Betty Chewning
Introduction: Pharmacist roles promoting safe opioid use are recognized in literature and practice. Pharmacists can offer services such as counseling on opioid risks, naloxone dispensing, education on opioid storage and disposal, prescription drug monitoring program (PDMP) utilization, opioid deprescribing, and providing resources for addiction treatment to help mitigate the opioid crisis. Objective: This commentary seeks to describe current and potential roles for pharmacists to combat the United States opioid crisis and identify key factors affecting service provision. Methods: The paper summarizes evidence-based studies describing current pharmacist roles and services, factors affecting service implementation, and strategies to further improve pharmacist roles and services related to promoting safe opioid use for patients. Results: Pharmacists recognize their roles and responsibilities to counsel patients on opioid risks, dispense naloxone, educate on opioid storage and disposal, utilize prescription drug monitoring programs (PDMPs), offer opioid deprescribing, and provide resources for addiction treatment. However, pharmacists express low confidence, time, and training as barriers to service provision. This suggests a need for structured training, resources, and organizational support for pharmacists to improve confidence and participation in such services. Conclusions: Although pharmacists are aware of roles and responsibilities to help reduce the opioid crisis, more training, education, organizational support and resources are needed to increase their ability to embody these roles.

29 June 2006 in BMJ
Verified
Journal Article
Closed access
PDF file
BCBetty Chewning
Betty Chewning
Footnotes Competing interests None declared.